iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

Segment Reporting (Tables)

6 Months Ended

Dec. 31, 2014

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Geographic segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.

			iBio
Three months ended December 31, 2014	iBio		Brazil		Total

Net revenues	$	367	$	-	$	367
Research and development expenses		731		-		731
General and administrative expenses		1,272		30		1,302
Operating loss		(1,636)		(30)		(1,666)

			iBio
Six months ended December 31, 2014	iBio		Brazil		Total

Net revenues	$	1,186	$	-	$	1,186
Research and development expenses		1,916		-		1,916
General and administrative expenses		2,301		51		2,352
Operating loss		(3,031)		(51)		(3,082)
Total assets		10,939		103		11,042

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details